Denosumab for Treatment of Hypercalcemia of MalignancyMimi I. Hu, Rajul K. Jain, Arnaud Jaccard et al.|The Journal of Clinical Endocrinology & Metabolism|2014Cited by 200
Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single‐arm studyJames R. Berenson, Regina A. Swift, Joseph Volk et al.|British Journal of Haematology|2006Cited by 83
A Multicenter Phase II Study of Combination Treatment with Melphalan, Arsenic Trioxide and Vitamin C (MAC) for Patients with Relapsed or Refractory Multiple Myeloma.James R. Berenson, Sal Bevivino, Marshall S. Flam et al.|Blood|2005Cited by 5